Lung Cancer | Leveraging the Immune System for Therapeutic Benefit in Non-Small Cell Lung Cancer: Scientific Insights, Clinical Applications and Future Directions
Faculty presentations from a CME symposium held at the 2019 AACR
Annual Meeting. Featuring perspectives from Drs Corey J Langer,
Vali A Papadimitrakopoulou, Naiyer Rizvi and David R Spigel.
Immune Checkpoint Inhibition in the Management of Locally
Advanced Non-Small Cell Lung Cancer (NSCLC) — Dr Langer
(00:00)
Incidence, Recognition and Management of Immune-Mediated and
Other Toxicities with the Use of Anti-PD-1/PD-L1 Antibodies for
Locally Advanced and Metastatic Disease — Dr Papadimitrakopoulou
(11:08)
Current Application of Immune Checkpoint Inhibitors in the
Treatment of Metastatic NSCLC; Role for Patients with Actionable
Tumor Mutations — Dr Spigel (22:52)
Future Directions for Clinical and Translational Research — Dr
Rizvi (34:22)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.